NIH-funded research R01 grant

Identifying Hidden Cardiac Amyloidosis in Black V122I TTR Carriers

Official title: IDENTIFYING SUBCLINICAL TRANSTHYRETIN CARDIAC AMYLOIDOSIS IN ASYMPTOMATIC CARRIERS OF THE V122I TTR ALLELE

Funded at Ut Southwestern Medical Center · NIH-11393304 · Data updated 2026-11-12

This project looks for early signs of heart damage in Black individuals who carry the V122I TTR variant and may benefit from new treatments if caught early.

More Amyloidosis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUt Southwestern Medical Center
NIH-funded
Lab location1 site (Dallas, United States)
Project startJuly 1, 2022
Project endJune 30, 2027
Funding year2026
Award (this year)$692,660
NIH project number5R01HL160892-05
Project IDNIH-11393304 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are Black adults who carry the V122I TTR variant and are asymptomatic or have no overt cardiac symptoms.

Less likely to help

Individuals who do not carry the V122I TTR variant or who already have diagnosed advanced heart disease may not benefit from this specific screening approach.

What this research studies

We will study Black adults who carry the V122I TTR gene variant to see if there are early, subclinical signs of cardiac amyloidosis using imaging and biomarkers. The research will compare carriers to non-carriers to understand how the heart’s structure and function change before symptoms appear. By identifying specific biomarkers and MRI findings, doctors could diagnose hATTR-CA earlier and start therapies sooner. The study will combine imaging data, blood tests, and clinical information to map the progression from carrier status to subclinical disease.

Why it matters

Potential benefit: If successful, the work could lead to earlier detection and treatment of hereditary cardiac amyloidosis in Black patients carrying the V122I TTR variant.

How similar studies have gone: Preliminary work suggests subclinical amyloid changes can be detected with imaging and biomarkers in carriers, supporting further study.

Where this research is happening

  • Ut Southwestern Medical Center
    Dallas, United States
    Active

Researchers

  • Principal investigator: Grodin, Justin Lee — Ut Southwestern Medical Center
  • Study coordinator: Grodin, Justin Lee

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.